Price
Target price
€13.11
€13.11
-0.530%
-0.07
-0.530%
€19.19
06.02.26 / Tradegate
WKN: A12EV9 / Symbol: DVAX / Name: Dynavax / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dynavax Technologies Corp Stock
Dynavax Technologies Corp shows a slight decrease today, losing -€0.070 (-0.530%) compared to yesterday.
Based on 2 Buy predictions and 1 Sell predictions the sentiment towards Dynavax Technologies Corp is rather balanced.
As a result the target price of 19 € shows a positive potential of 44.93% compared to the current price of 13.11 € for Dynavax Technologies Corp.
Pros and Cons of Dynavax Technologies Corp in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dynavax Technologies Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dynavax Technologies Corp | -0.530% | 0.344% | -0.757% | 3.883% | 0.383% | 20.874% | 66.879% |
| Evolus Inc | -2.140% | -7.576% | -26.210% | -71.181% | -32.844% | -57.442% | -36.237% |
| Madrigal Pharmaceuticals inc. | 1.980% | -2.180% | -15.435% | 27.021% | -18.997% | 56.512% | 304.934% |
| Heron Therapeutics Inc. | 2.350% | -5.009% | 1.336% | -38.542% | -4.668% | -64.997% | -93.440% |
Comments
Dynavax Technologies (NASDAQ:DVAX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies Co. (NASDAQ: DVAX) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $12.00 to $10.00. They now have a "sell" rating on the stock.
Show more
Ratings data for DVAX provided by MarketBeat
Dynavax Technologies Co. (NASDAQ: DVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $31.00 price target on the stock.
Show more
Ratings data for DVAX provided by MarketBeat
News
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
David Novack, President & COO of Dynavax Technologies Corporation (NASDAQ:DVAX), exercised 114,000 stock options and immediately sold the resulting shares for a transaction value of approximately
Why Dynavax Stock Soared Today
Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by Sanofi (NASDAQ: SNY).
As of 3:00 p.m. EST, Dynavax's stock price was up